Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Absorption Systems Publishes CellPort Study

April 26, 2011 7:44 am | News | Comments

Absorption Systems announced the results of another study demonstrating the power of the company’s CellPort Technologies to predict the potential for pharmacokinetic drug-drug interactions.

TOPICS:

Protease Inhibitors

April 25, 2011 8:23 am | Product Releases | Comments

The ProteaseArrest family of protease inhibitor cocktails are unique ready-to-use liquid format cocktails that offer immediate >98% inhibition of harmful proteases.

TOPICS:

3D Cell Culture

April 25, 2011 8:20 am | Product Releases | Comments

AMSBIO has announced the launch of Alvetex, a cell culture scaffold that enables genuine 3D cell culture to be grown routinely and cost-effectively.

TOPICS:
Advertisement

Merck, Sanofi Team on Phase 3 Trial

April 25, 2011 8:13 am | News | Comments

Merck and Sanofi Pasteur announced the initiation of a Phase 3 clinical program to evaluate the safety and immunogenicity of an investigational pediatric hexavalent combination vaccine.

TOPICS:

Higher Losses for Pharmasset in 2Q

April 25, 2011 8:10 am | News | Comments

Clinical-stage drugmaker Pharmasset Inc. reported a wider fiscal second-quarter loss Monday on higher research and development costs. The company lost $19.9 million, or 55 cents per share, in the quarter ended March 31.

TOPICS:

Drug Combo Provides Hope for Cystic Fibrosis Patients

April 25, 2011 8:02 am | News | Comments

An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

TOPICS:

Artificially Malaria Immunity Lasts Longer Than Natural Immunity

April 25, 2011 7:50 am | News | Comments

A new immunological technique, in which patients are infected with malaria at the same time as being treated with prophylactic chloroquinine drugs, can give immunity against re-infection for at least 2.5 years, much longer than for immunity acquired naturally.

TOPICS:

Mylan Launches Generic Femara

April 25, 2011 7:42 am | News | Comments

Generic drugmaker Mylan Inc. said it has launched a generic version of Novartis' breast cancer treatment Femara. Mylan and Novartis settled a patent dispute over the drug in 2008.

TOPICS:
Advertisement

FDA Approves First Meningococcal Vaccine for Young Children

April 25, 2011 7:40 am | News | Comments

The U.S. Food and Drug Administration approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.

TOPICS:

FDA Posts Positive Review of Boceprevir

April 25, 2011 7:37 am | by Matthew Perrone | News | Comments

Federal health officials said a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years.

TOPICS:

AstraZeneca, Pozen Filing Vimovo Lawsuit

April 25, 2011 7:34 am | News | Comments

Pozen Inc. said that it filed a patent infringement lawsuit against generic drugmaker Dr. Reddy's Laboratories Ltd., which is seeking approval for a generic version of its osteoarthritis drug Vimovo.

TOPICS:

Compound Offers Treatment of Adult Shingles

April 22, 2011 7:40 am | News | Comments

Researchers have discovered a compound called L-BHDA that has the potential to be more effective than existing agents in treating the very painful blisters known as shingles.

TOPICS:

Drug Effective in Treating Kidney Disease in Diabetic Patients

April 22, 2011 7:37 am | by Debra Kain | News | Comments

Researchers have published promising results of a clinical study using pirfenidone, an experimental anti-fibrotic and anti-inflammatory drug, to treat patients with diabetic nephropathy.

TOPICS:

Nanoscale Vaults Encapsulate Nanodisks for Drug Delivery

April 22, 2011 7:33 am | by Jennifer Marcus, UCLA | News | Comments

UCLA researchers have demonstrated the ability to package drug-loaded "nanodisks" into naturally occurring nanoscale capsules that have been engineered for therapeutic drug delivery.

TOPICS:

Early Warning System for Alzheimer's Disease

April 22, 2011 7:22 am | News | Comments

Scientists are developing a technique based on a new discovery which could pave the way towards detecting Alzheimer's disease in its earliest stages.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading